O	0	2	No
O	3	9	effect
O	10	12	of
B-intervention	13	21	exercise
O	22	24	on
O	25	32	urinary
O	33	34	6
O	34	35	-
O	35	53	sulfatoxymelatonin
O	54	57	and
O	58	72	catecholamines
O	73	75	in
O	76	81	young
O	82	87	women
O	88	101	participating
O	102	104	in
O	105	106	a
O	107	109	16
O	109	110	-
O	110	114	week
O	115	125	randomized
O	126	136	controlled
O	137	142	trial
O	142	143	.

O	144	149	Women
O	150	154	with
O	155	161	breast
O	162	168	cancer
O	169	173	have
O	174	183	decreased
O	184	190	levels
O	191	193	of
O	194	203	melatonin
O	204	206	or
O	207	210	its
O	211	221	metabolite
O	222	224	in
O	225	231	plasma
O	232	235	and
O	235	236	/
O	236	238	or
O	239	244	urine
O	244	245	.

O	246	248	We
O	249	257	measured
O	258	263	serum
O	264	273	melatonin
O	273	274	,
O	275	282	urinary
O	283	284	6
O	284	285	-
O	285	303	sulfatoxymelatonin
O	303	304	,
O	305	319	catecholamines
O	319	320	,
O	321	324	and
O	325	333	cortisol
O	334	336	in
B-total-participants	337	340	141
B-eligibility	341	350	sedentary
I-eligibility	351	356	young
I-eligibility	357	363	female
I-eligibility	364	376	participants
O	377	379	in
O	380	381	a
O	382	390	clinical
O	391	396	trial
O	397	406	comparing
O	407	410	150
O	411	414	min
O	414	415	/
O	415	417	wk
O	418	425	aerobic
O	426	434	exercise
O	435	438	for
O	439	440	4
O	441	447	months
O	448	450	to
B-control	451	453	no
I-control	453	454	-
I-control	454	462	exercise
I-control	463	471	controls
O	471	472	.

O	473	485	Demographics
O	485	486	,
O	487	493	health
O	494	501	surveys
O	501	502	,
O	503	507	body
O	508	519	composition
O	519	520	,
O	521	526	sleep
O	527	534	quality
O	534	535	,
O	536	543	fitness
O	544	550	levels
O	550	551	,
O	552	555	and
O	556	561	blood
O	562	565	and
O	566	571	urine
O	572	579	samples
O	580	584	were
O	585	593	obtained
O	594	596	at
O	597	605	baseline
O	606	609	and
O	610	612	16
O	613	618	weeks
O	618	619	.

O	620	625	There
O	626	630	were
O	631	633	no
O	634	645	differences
O	646	653	between
O	654	660	groups
O	661	663	at
O	664	672	baseline
O	673	675	in
B-outcome	676	688	demographics
I-outcome	688	689	,
I-outcome	690	698	exercise
I-outcome	698	699	,
I-outcome	700	705	sleep
I-outcome	706	712	habits
I-outcome	712	713	,
I-outcome	714	716	or
I-outcome	717	722	study
I-outcome	723	731	hormones
O	731	732	.

O	733	738	There
O	739	743	were
O	744	748	also
O	749	751	no
O	752	763	significant
O	764	775	differences
O	776	783	between
O	784	790	groups
O	791	793	in
O	794	797	any
O	798	800	of
O	801	804	the
B-outcome	805	813	hormones
O	814	816	at
O	817	819	16
O	820	825	weeks
O	825	826	.

O	827	834	Sixteen
O	835	840	weeks
O	841	843	of
O	844	852	exercise
O	853	856	had
O	857	864	minimal
O	865	872	effects
O	873	875	on
B-outcome	876	885	melatonin
I-outcome	886	895	secretion
O	896	898	of
O	899	904	young
O	905	910	women
O	910	911	.

O	912	917	There
O	918	920	is
O	921	931	convincing
O	932	940	evidence
O	941	945	that
O	946	954	exercise
O	955	963	protects
O	964	971	against
O	972	978	breast
O	979	985	cancer
O	985	986	,
O	987	990	but
O	991	995	this
O	996	1000	does
O	1001	1004	not
O	1005	1011	appear
O	1012	1014	to
O	1015	1020	occur
O	1021	1028	through
O	1029	1036	changes
O	1037	1039	in
O	1040	1049	melatonin
O	1050	1059	secretion
O	1059	1060	.
